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background:  The characteristics and prognostic significance of different clinical presentations of new-onset atrial fibrillation (AF) remain 
largely unknown.
Methods:  The type of clinical presentation was determined by review of electronic medical records in a randomly selected sample of 640 
patients with incident AF from Olmsted County, Minnesota (2000-2010). We examined associations of AF presentation [typical (palpitations) 
vs. other] with patient demographic and clinical characteristics as well as with the risks for cerebrovascular events (CVE; includes ischemic 
strokes and transient ischemic attacks) and all-cause and cardiovascular death.
results:  Among the 608 (95%) AF cases (mean age 72.4 years, 52% female) where the type of presentation could be determined, 119 
(19%) had typical symptoms. The distribution of other presentations was as follows: atypical (dyspnea, lightheadedness, etc) n=84 (14%), 
CVE n=18 (3%), asymptomatic (incidental diagnosis) n=112 (18%), provoked (in the setting of other acute systemic or cardiac illness) 
n=228 (38%), heart failure n=42 (7%), miscellaneous n=5 (1%). Patients with typical presentations were significantly more likely to be 
younger, have higher left ventricular ejection fraction and lower CHA2DS2-VASc score (all p<0.001). A total of 73 patients experienced CVE 
and 323 died (cardiovascular causes n=120) after median follow-up of 3.9 and 4.3 years, respectively. After adjustment for age, sex, and 
CHA2DS2-VASc score, patients with typical presentations suffered significantly fewer CVEs compared to others (hazard ratio (HR) 0.32, 
95% confidence interval (CI) 0.13-0.80, p=0.016). In addition, those with typical presentations experienced a lower risk of all-cause and 
cardiovascular mortality (HR 0.34, 95% CI 0.22-0.52, p<0.001 and HR 0.50, 95% CI 0.26-0.94, p=0.031, respectively).
Conclusion:  The majority of AF patients present with atypical or no symptoms. AF manifesting with typical symptoms may represent a 
more benign variant with regards to embolic and mortality risks. Further research can help clarify whether these differences in morbidity 
and mortality are due to different treatment strategies or other mediators.
